{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:47:55Z","timestamp":1793778475475,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-023-01007-3","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T17:03:14Z","timestamp":1676566994000},"page":"629-646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington\u2019s disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Sen","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuchi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-3063","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weien","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-6802","authenticated-orcid":false,"given":"Liangxue","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-6536","authenticated-orcid":false,"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"1007_CR1","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1007_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-011110-130242","volume":"6","author":"JM Shulman","year":"2011","unstructured":"Shulman, J. M., De Jager, P. L. & Feany, M. B. Parkinson\u2019s disease: genetics and pathogenesis. Annu. Rev. Pathol. 6, 193\u2013222 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"1007_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims, R., Hill, M. & Williams, J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat. Neurosci. 23, 311\u2013322 (2020).","journal-title":"Nat. Neurosci."},{"key":"1007_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180\u2013186 (2016).","journal-title":"Nature"},{"key":"1007_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.conb.2021.07.001","volume":"72","author":"EL Bunting","year":"2022","unstructured":"Bunting, E. L., Hamilton, J. & Tabrizi, S. J. Polyglutamine diseases. Curr. Opin. Neurobiol. 72, 39\u201347 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1007_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","volume":"14","author":"AP Lieberman","year":"2019","unstructured":"Lieberman, A. P., Shakkottai, V. G. & Albin, R. L. Polyglutamine repeats in neurodegenerative diseases. Annu. Rev. Pathol. 14, 1\u201327 (2019).","journal-title":"Annu. Rev. Pathol."},{"key":"1007_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575\u2013621 (2007).","journal-title":"Annu. Rev. Neurosci."},{"key":"1007_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.26020","volume":"29","author":"N Aronin","year":"2014","unstructured":"Aronin, N. & DiFiglia, M. Huntingtin-lowering strategies in Huntington\u2019s disease: antisense oligonucleotides, small RNAs, and gene editing. Mov. Disord. 29, 1455\u20131461 (2014).","journal-title":"Mov. Disord."},{"key":"1007_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","volume":"42","author":"CF Bennett","year":"2019","unstructured":"Bennett, C. F., Krainer, A. R. & Cleveland, D. W. Antisense oligonucleotide therapies for neurodegenerative diseases. Annu. Rev. Neurosci. 42, 385\u2013406 (2019).","journal-title":"Annu. Rev. Neurosci."},{"key":"1007_CR10","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41582-018-0096-6","volume":"14","author":"I Fyfe","year":"2018","unstructured":"Fyfe, I. Antisense oligonucleotides improve cognitive function in HD model. Nat. Rev. Neurol. 14, 690\u2013691 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1007_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz, H. B. et al. Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74, 1031\u20131044 (2012).","journal-title":"Neuron"},{"key":"1007_CR13","doi-asserted-by":"publisher","first-page":"eaar3959","DOI":"10.1126\/scitranslmed.aar3959","volume":"10","author":"AL Southwell","year":"2018","unstructured":"Southwell, A. L. et al. Huntingtin suppression restores cognitive function in a mouse model of Huntington\u2019s disease. Sci. Transl. Med. 10, eaar3959 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1007_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/mt.2008.50","volume":"16","author":"NR Franich","year":"2008","unstructured":"Franich, N. R. et al. AAV vector\u2013mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington\u2019s disease. Mol. Ther. 16, 947\u2013956 (2008).","journal-title":"Mol. Ther."},{"key":"1007_CR15","doi-asserted-by":"crossref","unstructured":"Matos, C. A. et al. in Polyglutamine Disorders (eds N\u00f3brega, C. & Pereira de Almeida, L.) 395\u2013438 (Springer, 2018).","DOI":"10.1007\/978-3-319-71779-1_20"},{"key":"1007_CR16","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/mt.2011.219","volume":"19","author":"JL McBride","year":"2011","unstructured":"McBride, J. L. et al. Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease. Mol. Ther. 19, 2152\u20132162 (2011).","journal-title":"Mol. Ther."},{"key":"1007_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.omtm.2019.03.002","volume":"13","author":"EA Spronck","year":"2019","unstructured":"Spronck, E. A. et al. AAV5-miHTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models. Mol. Ther. Methods Clin. Dev. 13, 334\u2013343 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1007_CR18","doi-asserted-by":"publisher","first-page":"eabb8920","DOI":"10.1126\/scitranslmed.abb8920","volume":"13","author":"A Vall\u00e8s","year":"2021","unstructured":"Vall\u00e8s, A. et al. Widespread and sustained target engagement in Huntington\u2019s disease minipigs upon intrastriatal microRNA-based gene therapy. Sci. Transl. Med. 13, eabb8920 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1007_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1089\/nat.2018.0775","volume":"29","author":"M Imbert","year":"2019","unstructured":"Imbert, M., Blandel, F., Leumann, C., Garcia, L. & Goyenvalle, A. Lowering mutant huntingtin using tricyclo-DNA antisense oligonucleotides as a therapeutic approach for Huntington\u2019s disease. Nucleic Acid Ther. 29, 256\u2013265 (2019).","journal-title":"Nucleic Acid Ther."},{"key":"1007_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/brain\/awz328","volume":"143","author":"AC Silva","year":"2020","unstructured":"Silva, A. C. et al. Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders. Brain 143, 407\u2013429 (2020).","journal-title":"Brain"},{"key":"1007_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","volume":"20","author":"K Kingwell","year":"2021","unstructured":"Kingwell, K. Double setback for ASO trials in Huntington disease. Nat. Rev. Drug Discov. 20, 412\u2013413 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1007_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","volume":"6","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer\u2019s disease alleviates amyloid-related pathologies in mice. Nat. Biomed. Eng. 6, 168\u2013180 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1007_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","volume":"17","author":"FK Ekman","year":"2019","unstructured":"Ekman, F. K. et al. CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington\u2019s disease mouse model. Mol. Ther. Nucleic Acids 17, 829\u2013839 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1007_CR24","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Invest. 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Invest."},{"key":"1007_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0321-9","volume":"14","author":"W Yang","year":"2019","unstructured":"Yang, W., Li, S. & Li, X.-J. A CRISPR monkey model unravels a unique function of PINK1 in primate brains. Mol. Neurodegener. 14, 17 (2019).","journal-title":"Mol. Neurodegener."},{"key":"1007_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41586-019-1278-0","volume":"570","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Atypical behaviour and connectivity in SHANK3-mutant macaques. Nature 570, 326\u2013331 (2019).","journal-title":"Nature"},{"key":"1007_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-neuro-080317-062048","volume":"41","author":"CN Bedbrook","year":"2018","unstructured":"Bedbrook, C. N., Deverman, B. E. & Gradinaru, V. Viral strategies for targeting the central and peripheral nervous systems. Annu.Rev. Neurosci. 41, 323\u2013348 (2018).","journal-title":"Annu.Rev. Neurosci."},{"key":"1007_CR28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"1007_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1007_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","volume":"25","author":"D Goertsen","year":"2022","unstructured":"Goertsen, D. et al. AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset. Nat. Neurosci. 25, 106\u2013115 (2022).","journal-title":"Nat. Neurosci."},{"key":"1007_CR31","doi-asserted-by":"publisher","first-page":"eabd5758","DOI":"10.1126\/scitranslmed.abd5758","volume":"13","author":"JK Lunney","year":"2021","unstructured":"Lunney, J. K. et al. Importance of the pig as a human biomedical model. Sci. Transl. Med. 13, eabd5758 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1007_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.neubiorev.2007.02.003","volume":"31","author":"NM Lind","year":"2007","unstructured":"Lind, N. M. et al. The use of pigs in neuroscience: modeling brain disorders. Neurosci. Biobehav. Rev. 31, 728\u2013751 (2007).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1007_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","volume":"26","author":"A Moretti","year":"2020","unstructured":"Moretti, A. et al. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat. Med. 26, 207\u2013214 (2020).","journal-title":"Nat. Med."},{"key":"1007_CR34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","volume":"173","author":"S Yan","year":"2018","unstructured":"Yan, S. et al. A Huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease. Cell 173, 989\u20131002.e13 (2018).","journal-title":"Cell"},{"key":"1007_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59\u201365 (2009).","journal-title":"Nat. Biotechnol."},{"key":"1007_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mt.2009.15","volume":"17","author":"FP Manfredsson","year":"2009","unstructured":"Manfredsson, F. P., Rising, A. C. & Mandel, R. J. AAV9: a potential blood-brain barrier buster. Mol. Ther. 17, 403\u2013405 (2009).","journal-title":"Mol. Ther."},{"key":"1007_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1517\/14712598.2012.681463","volume":"12","author":"RD Dayton","year":"2012","unstructured":"Dayton, R. D., Wang, D. B. & Klein, R. L. The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin. Biol. Ther. 12, 757\u2013766 (2012).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1007_CR38","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","volume":"101","author":"E Hudry","year":"2019","unstructured":"Hudry, E. & Vandenberghe, L. H. Therapeutic AAV gene transfer to the nervous system: a clinical reality. Neuron 101, 839\u2013862 (2019).","journal-title":"Neuron"},{"key":"1007_CR39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir, J. et al. Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811\u2013823 (1995).","journal-title":"Cell"},{"key":"1007_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin, S., Liu, J.-P., Chapman, D. L., Papaioannou, V. E. & Efstratiadis, A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat. Genet. 11, 155\u2013163 (1995).","journal-title":"Nat. Genet."},{"key":"1007_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1385\/MN:28:3:259","volume":"28","author":"A Reiner","year":"2003","unstructured":"Reiner, A., Dragatsis, I., Zeitlin, S. & Goldowitz, D. Wild-type huntingtin plays a role in brain development and neuronal survival. Mol. Neurobiol. 28, 259\u2013275 (2003).","journal-title":"Mol. Neurobiol."},{"key":"1007_CR42","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1073\/pnas.1524575113","volume":"113","author":"G Wang","year":"2016","unstructured":"Wang, G., Liu, X., Gaertig, M. A., Li, S. & Li, X.-J. Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis. Proc. Natl Acad. Sci. USA 113, 3359\u20133364 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1007_CR43","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.neuron.2019.05.001","volume":"102","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J., Ghosh, R. & Leavitt, B. R. Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron 102, 899 (2019).","journal-title":"Neuron"},{"key":"1007_CR44","first-page":"3","volume":"9","author":"WF Kaemmerer","year":"2019","unstructured":"Kaemmerer, W. F. & Grondin, R. C. The effects of huntingtin-lowering: what do we know so far? Degener. Neurol. Neuromuscul. Dis. 9, 3\u201317 (2019).","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"1007_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"1007_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1139\/bcb-2016-0137","volume":"95","author":"J Salsman","year":"2017","unstructured":"Salsman, J. & Dellaire, G. Precision genome editing in the CRISPR era. Biochem. Cell Biol. 95, 187\u2013201 (2017).","journal-title":"Biochem. Cell Biol."},{"key":"1007_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1083\/jcb.200710158","volume":"181","author":"C-E Wang","year":"2008","unstructured":"Wang, C.-E. et al. Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. J. Cell Biol. 181, 803\u2013816 (2008).","journal-title":"J. Cell Biol."},{"key":"1007_CR48","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","volume":"26","author":"MM Evers","year":"2018","unstructured":"Evers, M. M. et al. AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington\u2019s disease minipig model. Mol. Ther. 26, 2163\u20132177 (2018).","journal-title":"Mol. Ther."},{"key":"1007_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder, P. et al. Integrated genomics and proteomics define huntingtin CAG length\u2013dependent networks in mice. Nat. Neurosci. 19, 623\u2013633 (2016).","journal-title":"Nat. Neurosci."},{"key":"1007_CR50","doi-asserted-by":"publisher","first-page":"751033","DOI":"10.3389\/fgene.2021.751033","volume":"12","author":"B Malla","year":"2021","unstructured":"Malla, B., Guo, X., Senger, G., Chasapopoulou, Z. & Yildirim, F. A systematic review of transcriptional dysregulation in Huntington\u2019s disease studied by RNA sequencing. Front. Genet. 12, 751033 (2021).","journal-title":"Front. Genet."},{"key":"1007_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","volume":"72","author":"B Woodman","year":"2007","unstructured":"Woodman, B. et al. The HdhQ150\/Q150 knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res. Bull. 72, 83\u201397 (2007).","journal-title":"Brain Res. Bull."},{"key":"1007_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","volume":"14","author":"C Rinaldi","year":"2018","unstructured":"Rinaldi, C. & Wood, M. J. A. Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat. Rev. Neurol. 14, 9\u201321 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1007_CR53","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","volume":"94","author":"KM Schoch","year":"2017","unstructured":"Schoch, K. M. & Miller, T. M. Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases. Neuron 94, 1056\u20131070 (2017).","journal-title":"Neuron"},{"key":"1007_CR54","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ijms21062146","volume":"21","author":"F Marxreiter","year":"2020","unstructured":"Marxreiter, F., Stemick, J. & Kohl, Z. Huntingtin lowering strategies. Int. J. Mol. Sci. 21, 2146 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1007_CR55","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41591-019-0478-3","volume":"25","author":"B Zeitler","year":"2019","unstructured":"Zeitler, B. et al. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington\u2019s disease. Nat. Med. 25, 1131\u20131142 (2019).","journal-title":"Nat. Med."},{"key":"1007_CR56","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","volume":"2","author":"LB Menalled","year":"2005","unstructured":"Menalled, L. B. Knock-in mouse models of Huntington\u2019s disease. Neurotherapeutics 2, 465\u2013470 (2005).","journal-title":"Neurotherapeutics"},{"key":"1007_CR57","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1017\/S1751731109004649","volume":"3","author":"P Sauleau","year":"2009","unstructured":"Sauleau, P., Lapouble, E., Val-Laillet, D. & Malbert, C.-H. The pig model in brain imaging and neurosurgery. Animal 3, 1138\u20131151 (2009).","journal-title":"Animal"},{"key":"1007_CR58","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fgene.2015.00293","volume":"6","author":"K Gutierrez","year":"2015","unstructured":"Gutierrez, K., Dicks, N., Glanzner, W., Agellon, L. & Bordignon, V. Efficacy of the porcine species in biomedical research. Front. Genet. 6, 293 (2015).","journal-title":"Front. Genet."},{"key":"1007_CR59","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/0192623315609688","volume":"44","author":"N Klymiuk","year":"2016","unstructured":"Klymiuk, N. et al. Tailored pig models for preclinical efficacy and safety testing of targeted therapies. Toxicol. Pathol. 44, 346\u2013357 (2016).","journal-title":"Toxicol. Pathol."},{"key":"1007_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","volume":"20","author":"F Meurens","year":"2012","unstructured":"Meurens, F., Summerfield, A., Nauwynck, H., Saif, L. & Gerdts, V. The pig: a model for human infectious diseases. Trends Microbiol. 20, 50\u201357 (2012).","journal-title":"Trends Microbiol."},{"key":"1007_CR61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00441-020-03206-9","volume":"380","author":"R Pabst","year":"2020","unstructured":"Pabst, R. The pig as a model for immunology research. Cell Tissue Res. 380, 287\u2013304 (2020).","journal-title":"Cell Tissue Res."},{"key":"1007_CR62","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300985811402846","volume":"49","author":"MM Swindle","year":"2012","unstructured":"Swindle, M. M., Makin, A., Herron, A. J., Clubb, F. J. & Frazier, K. S. Swine as models in biomedical research and toxicology testing. Vet. Pathol. 49, 344\u2013356 (2012).","journal-title":"Vet. Pathol."},{"key":"1007_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/mt.2013.266","volume":"22","author":"L Samaranch","year":"2014","unstructured":"Samaranch, L. et al. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Mol. Ther. 22, 329\u2013337 (2014).","journal-title":"Mol. Ther."},{"key":"1007_CR64","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.omtm.2021.09.017","volume":"23","author":"S Marc\u00f3","year":"2021","unstructured":"Marc\u00f3, S. et al. Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal. Mol. Ther. Methods Clin. Dev. 23, 370\u2013389 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1007_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jevs.2016.03.008","volume":"41","author":"J West","year":"2016","unstructured":"West, J. & Gill, W. W. Genome editing in large animals. J. Equine Vet. Sci. 41, 1\u20136 (2016).","journal-title":"J. Equine Vet. Sci."},{"key":"1007_CR66","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/nsr\/nwz013","volume":"6","author":"J Zhao","year":"2019","unstructured":"Zhao, J., Lai, L., Ji, W. & Zhou, Q. Genome editing in large animals: current status and future prospects. Natl Sci. Rev. 6, 402\u2013420 (2019).","journal-title":"Natl Sci. Rev."},{"key":"1007_CR67","doi-asserted-by":"publisher","first-page":"104963","DOI":"10.1016\/j.nbd.2020.104963","volume":"143","author":"DK Wilton","year":"2020","unstructured":"Wilton, D. K. & Stevens, B. The contribution of glial cells to Huntington\u2019s disease pathogenesis. Neurobiol. Dis. 143, 104963 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1007_CR68","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","volume":"10","author":"VL Simhadri","year":"2018","unstructured":"Simhadri, V. L. et al. Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the USA population. Mol. Ther. Methods Clin. Dev. 10, 105\u2013112 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1007_CR69","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1007_CR70","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1007_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1007_CR72","doi-asserted-by":"publisher","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","volume":"49","author":"KL Howe","year":"2021","unstructured":"Howe, K. L. et al. Ensembl 2021. Nucleic Acids Res. 49, D884\u2013D891 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1007_CR73","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1007_CR74","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1007_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1007_CR76","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molp.2020.06.009","volume":"13","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. TBtools: an integrative toolkit developed for interactive analyses of big biological data. Mol. Plant 13, 1194\u20131202 (2020).","journal-title":"Mol. Plant"},{"key":"1007_CR77","doi-asserted-by":"publisher","unstructured":"Head, S. R. et al. Library construction for next-generation sequencing: overviews and challenges. Biotechniques https:\/\/doi.org\/10.2144\/000114133 (2014).","DOI":"10.2144\/000114133"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01007-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01007-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01007-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:24:15Z","timestamp":1684455855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-023-01007-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":77,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1038\/s41551-023-01007-3","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}